Skip to main content
Insomnia drug Dayvigo approved by FDA for adults
1/6/2020

The FDA recently approved Eisai's Dayvigo, or lemborexant, as a treatment for adults with insomnia who find it difficult to fall asleep and stay asleep. The drug could also prove beneficial to elderly patients with sleep-related issues caused by mild to moderate Alzheimer's disease.

Full Story: